Serina Therapeutics (SER) EBIT Growth (5y) (2023 - 2026)
Serina Therapeutics (SER) EBIT Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.20% |
| Dec 31, 2025 | -21.68% |
| Sep 30, 2025 | -21.67% |
| Jun 30, 2025 | -18.64% |
| Mar 31, 2025 | -14.26% |
| Dec 31, 2024 | -15.36% |
| Sep 30, 2024 | -10.13% |
| Jun 30, 2024 | -2.35% |
| Mar 31, 2024 | 5.76% |
| Dec 31, 2023 | 15.68% |
| Sep 30, 2023 | 7.85% |
| Jun 30, 2023 | 15.03% |
| Mar 31, 2023 | -24.78% |